|
End-of-day quote
Nasdaq
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
Company Valuation: Aptevo Therapeutics Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 36.9 | 10.88 | 3.394 | 2.155 | 8.828 | 3.305 | - | - |
| Change | - | -70.52% | -68.79% | -36.51% | 309.61% | -62.56% | - | - |
| Enterprise Value (EV) | 36.9 | 10.88 | 3.394 | 2.155 | 8.828 | 3.305 | 3.305 | 3.305 |
| Change | - | -70.52% | -68.79% | -36.51% | 309.61% | -62.56% | 0% | 0% |
| P/E | -1.3x | 1.48x | -0.13x | -0.05x | -0.11x | -0.07x | -0.19x | -0.2x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | -0x | 0x | 0x | 0x | 0x | 0x | 0.03x |
| Capitalization / Revenue | 3x | 3.49x | - | - | - | - | - | - |
| EV / Revenue | 0x | 0x | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -0.12x | -0.12x | -0.11x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -3,557,502 | 920,145 | -832,233 | -31,457 | -87.27 | -17.04 | -6.59 | -6.21 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 12.29 | 3.114 | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -21.4 | -28.64 | -28.88 | -24.6 | -26.31 | -26.93 | -28.64 | -30.1 |
| Net income 1 | -28.46 | 8.027 | -17.41 | -24.13 | -27.54 | -26.82 | -28.69 | -30.15 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 4,612,319.053 | 1,359,667.116 | 106,077.478 | 1,551.599 | 9.430 | 1.240 | 1.240 | 1.240 |
| Nbr of stocks (in thousands) | 0.01 | 0.01 | 0.03 | 1.39 | 936 | 2,665 | - | - |
| Announcement Date | 3/24/22 | 3/30/23 | 3/5/24 | 2/14/25 | 3/26/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.07x | - | - | - | 3.3M | |
| 17.43x | 6.6x | 12.65x | 1.71% | 65.94B | |
| 38.45x | 6.85x | 20.42x | 0.85% | 56.53B | |
| 30.07x | 8.27x | 26.77x | 0.06% | 56.88B | |
| 49.29x | 6.27x | 34.36x | -.--% | 46.49B | |
| 35.48x | 3.35x | 14.48x | -.--% | 44.8B | |
| -22.45x | 63.4x | -21.48x | -.--% | 41.59B | |
| 35.89x | 8.84x | 23.03x | 0.37% | 35.35B | |
| 37.6x | 8.06x | 26.12x | -.--% | 33.29B | |
| 28.81x | 6.09x | 15.79x | -.--% | 24.92B | |
| Average | 25.05x | 13.08x | 16.90x | 0.33% | 40.58B | |
| Weighted average by Cap. | 27.65x | 12.58x | 17.10x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- APVO Stock
- Valuation Aptevo Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
